[go: up one dir, main page]

MA37741B1 - Benzimidazole-proline derivatives - Google Patents

Benzimidazole-proline derivatives

Info

Publication number
MA37741B1
MA37741B1 MA37741A MA37741A MA37741B1 MA 37741 B1 MA37741 B1 MA 37741B1 MA 37741 A MA37741 A MA 37741A MA 37741 A MA37741 A MA 37741A MA 37741 B1 MA37741 B1 MA 37741B1
Authority
MA
Morocco
Prior art keywords
benzimidazole
formula
proline derivatives
compounds
proline
Prior art date
Application number
MA37741A
Other languages
French (fr)
Other versions
MA20150282A2 (en
Inventor
Christoph Boss
Christine Brotschi
Bibia Heidmann
Thierry Sifferlen
Markus Gude
Jodi T Williams
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2013/054567 external-priority patent/WO2013182972A1/en
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MA20150282A2 publication Critical patent/MA20150282A2/en
Publication of MA37741B1 publication Critical patent/MA37741B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne des composés de formule (i) - ar1, r1, r2, r3, r4a, r4b et (r5)n dans la formule étant tels que définis dans la description, leur préparation, leurs sels pharmaceutiquement acceptables, et leur utilisation à titre de produits pharmaceutiques. Des compositions pharmaceutiques contenant un ou plusieurs composés de formule (i), et notamment leur utilisation à titre d'antagonistes des récepteurs d'orexine sont également décrites.This invention relates to compounds of formula (I) - ar1, r1, r2, r3, r4a, r4b and (r5) n in the formula being as defined in the description, their preparation, their pharmaceutically acceptable salts, and their use in as pharmaceuticals. Pharmaceutical compositions containing one or more compounds of formula (i), and in particular their use as orexin receptor antagonists, are also described.

MA37741A 2012-06-04 2015-01-02 Benzimidazole-proline derivatives MA37741B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12170748 2012-06-04
PCT/IB2013/054567 WO2013182972A1 (en) 2012-06-04 2013-06-03 Benzimidazole-proline derivatives

Publications (2)

Publication Number Publication Date
MA20150282A2 MA20150282A2 (en) 2015-08-31
MA37741B1 true MA37741B1 (en) 2017-01-31

Family

ID=54338069

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37741A MA37741B1 (en) 2012-06-04 2015-01-02 Benzimidazole-proline derivatives

Country Status (2)

Country Link
MA (1) MA37741B1 (en)
UA (1) UA112586C2 (en)

Also Published As

Publication number Publication date
MA20150282A2 (en) 2015-08-31
UA112586C2 (en) 2016-09-26

Similar Documents

Publication Publication Date Title
MA38138A1 (en) New derivatives of quinolone
MA54653B1 (en) Modulators of the cxcr7 piperidine receptor
MA42230A (en) BICYCLIC DERIVATIVES, THEIR PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA37400B1 (en) Heterocyclyl compounds as mek inhibitors
MA38380A1 (en) Quinazoline inhibitors of activation of mutant forms of epidermal growth receptor (EGFR)
MA35348B1 (en) 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as inhibitors of btk
MA38391A1 (en) Pyridinyl and triazolone pyridinyl derivatives of fusion
MA34819B1 (en) BICYCLO [3.2.1] OCTYLAMIDE DERIVATIVES AND USES THEREOF
MA45222A (en) NEW PIPERIDINYL DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA35749B1 (en) Nucleoside derivatives 4'-azido, 3'-fluoro substituted as inhibitors of vhc arn replication
MA37886B1 (en) New bicyclic pyridinones
MA35024B1 (en) PYRROLO- [2,3-D] PYRIMIDINE DERIVATIVES AS INHIBITORS OF TROPOMYOSIN-RELATED KINASES
PH12014502540A1 (en) Benzimidazole-proline derivatives
MA34727B1 (en) CONDENSED IMIDAZOLYLIMIDAZOLES AS ANTIVIRAL COMPOUNDS
MA37891B1 (en) Alcoxypyrazoles as activators of soluble guanylate cyclase
MA35893B1 (en) Heterocyclic amide derivatives as p2x7 receptor antagonists
MA33384B1 (en) Heterocyclic sulfonamides, their uses and the pharmaceutical compositions they contain
TN2016000188A1 (en) 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS
MA49127B1 (en) N-substituted indole derivatives
MA38679B1 (en) Cxcr7 receiver modulators
MA38854B1 (en) Amide derivatives used as lysophosphatidic acid receptor antagonists
EA202191955A1 (en) MODIFIED RELEASE TABLET FORMULATIONS CONTAINING PHOSPHODIESTERASE INHIBITORS
MA31142B1 (en) HETEROARYL DERIVATIVES OF PYRROLIDINYL AND PIPERDINYL KERONES.
AR049711A1 (en) HETEROCICLIC COMPOUNDS CONDENSED AS INHIBITORS OF ALDOSTERONE SINTASA; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF DISEASES RELATED TO HYPERALDOSTERISM AND EXCESSIVE CORTISO RELEASE
CL2009001267A1 (en) Compounds derived from nitrogenous tricycles, with antibacterial activity; preparation procedure; pharmaceutical composition comprising them; for the treatment of tuberculosis.